Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Canan Kasikara
Pan-Tam Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-Pd-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer
Cancer Research
Cancer Research
Oncology
Related publications
Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy Against Triple-Negative Human Breast Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-Ron ADC Zt/G4-Mmae
Molecular Cancer Therapeutics
Cancer Research
Oncology
PD-L1 Expression in Triple-Negative Breast Cancer
Cancer immunology research
Cancer Research
Immunology
PIM-1 Kinase: A Potential Biomarker of Triple-Negative Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy
Pathology
Forensic Medicine
Pathology
Therapeutic Activity of DCC-2036, a Novel Tyrosine Kinase Inhibitor, Against Triple-Negative Breast Cancer Patient-Derived Xenografts by Targeting AXL/MET
International Journal of Cancer
Cancer Research
Oncology
Vitamin D Enhances the Efficacy of Photodynamic Therapy in a Murine Model of Breast Cancer
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
The Efficacy of Betulinic Acid in Triple-Negative Breast Cancer
SAGE Open Medicine
Medicine
Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer
Cancers
Cancer Research
Oncology